| Bioactivity | α-Amylase/α-Glucosidase-IN-3 (Compound 17) is an α-Amylase/α-Glucosidase dual inhibitor, with IC50s of 0.70 μM and 1.10 μM. α-Amylase/α-Glucosidase-IN-3 can be used for research of type-II diabetes mellitus[1]. |
| Name | α-Amylase/α-Glucosidase-IN-3 |
| Formula | C23H14Cl4N6O2S |
| Molar Mass | 580.27 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Khan I, et al. Synthesis and In Vitro α-Amylase and α-Glucosidase Dual Inhibitory Activities of 1,2,4-Triazole-Bearing bis-Hydrazone Derivatives and Their Molecular Docking Study. ACS Omega. 2023 Jun 5;8(25):22508-22522. |
α-Amylase/α-Glucosidase-IN-3
CAS: F: C23H14Cl4N6O2S W: 580.27
α-Amylase/α-Glucosidase-IN-3 (Compound 17) is an α-Amylase/α-Glucosidase dual inhibitor, with IC50s of 0.70 μM and
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.